Treatment with PDE-5 inhibitor resulted in decreased MDSC levels and partial restoration of ζ-chain expression in T cells, resulting in attenuated immunosuppressive function and significantly increased survival of tumor bearing mice, by a CD8+ T cell dependant mechanism (Meyer et al., 2011; Umansky and Sevko, 2012). Here, PDE5A is linked to neoplasm.